Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This is a Phase III open-labed, multicenter, prospective, randomised study, and comparative 3-arms of 140 patients (i.e. 420 total patients). Study period (date of first inclusion/last inclusion): 3 years Treatment period : 3 months
Critère d'inclusion
- Cancer